Is ARE up or down today?
ARE is up 2.42% today, last at 50.76. This stock moved +2.42% versus the prior close.
ARE · Alexandria Real Estate Equities
ARE (Alexandria Real Estate Equities) is trading at 50.76, up 2.42% on the session. ARE sits at the 23% mark of its 52-week range, carries a 14-day RSI of 49, and trades above its 50-day average. Over the past month it is up 5.49%.
Leading the coverage: “Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments” (PR Newswire, 7d ago). ARE is -3.66% since story.
ARE trades on a trailing P/E of 9.3 and is running 6.10% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
ARE is up 2.42% today, last at 50.76. This stock moved +2.42% versus the prior close.
Leading the coverage: “Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments” (PR Newswire, 7d ago). ARE is -3.66% since story. Dominant story: Alexandria Real Estate stock slips while analysts’ targets stay above market - ad-hoc-news.de (1 source, bearish) RSI is 49 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Alexandria Real Estate stock slips while analysts’ targets stay above market - ad-hoc-news.de
Alexandria Real Estate Chief Accounting Officer Sells 10,000 Shares
Alexandria’s (ARE) Profit Rebound Comes With A Cash Flow Catch
Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments
Alexandria Real Estate: We've Already Seen The Bottom, Next Is The Retest